Stockholm3 Versus Prostate-specific Antigen in Prostate Cancer Screening: 9-year Outcomes Demonstrating Improved Detection of Aggressive Cancers and Reduced Overdiagnosis from the STHLM3 Trial. - Vigneswaran, Hari T.; Palsdottir, Thorgerdur; Micoli, Chiara; Tilki, Derya; Lin, Daniel; Cooperberg, Matthew; Eggener, Scott; Falagario, Ugo Giovanni; Möller, Axel; Aly, Markus; Akre, Olof; Wiklund, Peter; et al. (European Urology, 2026)